The role of hepcidin in iron metabolism in inflammatory bowel diseases;Rola hepcydyny w metabolizmie zelaza w przebiegu nieswoistych zapaleń jelit

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 68, Issue , 2014, Pages 936-943

  Krawiec, Paulina ^a   Pac Kozuchowska, Elzbieta ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Anaemia; Hepcidin; Inflammatory bowel disease; Iron

Indexed keywords

BIOLOGICAL MARKER; CATION TRANSPORT PROTEIN; HEPCIDIN; IRON; METAL TRANSPORTING PROTEIN 1;

CHRONIC DISEASE; COMPLICATION; DOWN REGULATION; ENTERITIS; HOMEOSTASIS; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE CELL; IRON DEFICIENCY ANEMIA; LIVER; MACROPHAGE; METABOLISM;

ANEMIA, IRON-DEFICIENCY; BIOLOGICAL MARKERS; CATION TRANSPORT PROTEINS; CHRONIC DISEASE; DOWN-REGULATION; ENTERITIS; ENTEROCYTES; HEPCIDINS; HOMEOSTASIS; HUMANS; INFLAMMATORY BOWEL DISEASES; IRON; LIVER; MACROPHAGES;

EID: 84920578801     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: 10.5604/17322693.1111365     Document Type: Review

References (60)

1. Abboud S., Haile D.J.: A novel mammalian iron-regulated pro-tein involved in intracellular iron metabolism. J. Biol. Chem., 2000; 275: 19906-19912
2. Andrews N.C.: Forging a field: The golden age of iron biology. Blood, 2008; 112: 219-230
3. Andriopoulous B.Jr., Corradini E., Xia Y., Faasse S.A., Chen S., Grgu-revic L., Knutson M.D., Pietrangelo A., Vukicevic S., Lin H.Y., Babitt J.L.: BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat. Genet., 2009; 41: 482-487
4. Arnold J., Sangwaiya A., Bhatkal B., Geoghegan F., Busbridge M.: Hepcidin and inflammatory bowel disease: Dual role in host de-fence and iron homeostasis. Eur. J. Gastroenterol. Hepatol., 2009; 21: 425-429
5. Atanasiu V., Manolescu B., Stoian I.: Hepcidin - central regulator of iron metabolism. Eur. J. Haematol., 2007; 78: 1-10
6. Babitt J.L., Huang F.W., Wrighting D.M., Xia Y., Sidis Y., Samad T.A., Campagna J.A., Chung R.T., Schneyer A.L., Woolf C.J., Andrews N.C., Lin H.Y.: Bone morphogenetic protein signaling by hemoju-velin regulates hepcidin expression. Nat. Genet., 2006; 38: 531-539
7. Babitt J.L., Huang F.W., Xia Y., Sidis Y., Andrews N.C., Lin H.Y.: Mo-dulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. J. Clin. Invest., 2007; 117: 1933-1939
8. Bacchetta J., Zaritsky J.J., Sea J.L., Chun R.F., Lisse T.S., Zavala K., Nayak A., Wesseling-Perry K., Westerman M., Hollis B.W., Salusky I.B., Hewison M.: Suppression of iron-regulatory hepcidin by vitamin D. J. Am. Soc. Nephrol., 2014; 25: 564-572
9. Basseri R.J., Nemeth E., Vassilaki M.E., Basseri B., Enayati P., Shaye O., Bourikas L.A., Ganz T., Papadakis K.A.: Hepcidin is a key media-tor of anemia of inflammation in Crohn's disease. J. Crohns Colitis, 2013; 7: E286-e291
10. Bergamaschi G., Di Sabatino A., Albertini R., Costanzo F., Gu-erci M., Masotti M., Pasini A., Massari A., Campostrini N., Corbella M.,Girelli D., Corazza G.R.: Serum hepcidin in inflammatory bowel diseases: Biological and clinical significance. Inflamm. Bowel Dis., 2013; 19: 2166-2172
11. Bregman D.B., Morris D., Koch T.A., He A.,Goodnough L.T.: Hepci-din levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency. Am. J. Hematol., 2013; 88: 97-101
12. Dallalio G., Law E., Means R.T. Jr.: Hepcidin inhibits in vitro ery-throid colony formation at reduced erytropoietin concentration. Blood, 2006; 107: 2702-2704
13. De Domenico I., Ward D.M., Langelier C., Vaughn M.B., Nemeth E., Sundquist W.I., Ganz T., Musci G., Kaplan J.: The molecular me-chanism of hepcidin-mediated ferroportin down-regulation. Mol. Biol. Cell, 2007; 18: 2569-2578
14. Donovan A., Brownlie A., Zhou Y., Shepard J., Pratt S.J., Moyni-han J., Paw B.H., Drejer A., Barut B., Zapata A., Law T.C., Brugnara C., Lux S.E., Pinkus G.S., Pinkus J.L. i wsp.: Positional cloning of ze-brafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature, 2000; 403: 776-781
15. Evstatiev R., Gasche C.: Iron sensing and signaling. Gut, 2012; 61: 933-952
16. Galy B., Ferring-Appel D., Kaden S., Gröne H.J., Hentze M.W.: Iron regulatory proteins are essential for intestinal function and control key iron absorption molecules in the duodenum. Cell Me-tab., 2008; 7: 79-85
17. Ganz T.: Hepcidin, a key regulator of iron metabolism and me-diator of anemia of inflammation. Blood, 2003; 102: 783-788
18. Ganz T.: Iron homeostasis: Fitting the puzzle pieces together. Cell Metab., 2008; 7: 288-290
19. Ganz T., Nemeth E.: Iron imports. IV. Hepcidin and regulation of body iron metabolism. Am. J. Physiol. Gastrointest. Liver Physiol., 2006; 290: G199-G203
20. Ganz T., Olbina G., Girelli D., Nemeth E., Westerman M.: Immu-noassay for human serum hepcidin. Blood, 2008; 112: 4292-4297
21. Gasche C., Lomer M.C., Cavill I., Weiss G.: Iron, anaemia, and in-flammatory bowel diseases. Gut, 2004; 53: 1190-1197
22. Gomollón F., Gisbert J.P.: Anemia and inflammatory bowel dise-ases. World J. Gastroenterol., 2009; 15: 4659-4665
23. Huang H., Constante M., Layoun A., Santos M.M.: Contribution of STAT3 and STAT4 pathways to the regulation of hepcidin by op-posing stimuli. Blood, 2009; 113: 3593-3599
24. Kemna E., Tjalsma H., Laarakkers C., Nemeth E., Willems H., Swinkels D.: Novel urine hepcidin assay by mass spectrometry. Blo-od, 2005; 106: 3268-3270
25. Krause A., Neitz S., Mägert H.J., Schulz A., Forssmann W.G., Schulz-Knappe P., Adermann K.: LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett., 2000; 480: 147-150
26. Krzesiek E., Flis A., Iwańczak B.: Ocena występowania niedokrwi-stos̈ci we wrzodziejacym zapaleniu jelita grubego u dzieci. Pol. Merkur. Lekarski, 2012; 33: 138-142
27. Lee D.H., Zhou L.J., Zhou Z., Xie J.X., Jung J.U., Liu Y., Xi C.X., Mei L., Xiong W.C.: Neogenin inhibits HJV secretion and regulates BMP-induced hepcidin expression and iron homeostasis. Blood, 2010; 115: 3136-3145
28. Lee P.: Role of matriptase-2 (TMPRSS6) in iron metabolism. Acta Haematol., 2009; 122: 87-96
29. Lee P., Peng H., Gelbart T., Wang L., Beutler E.: Regulation of hepci-din transcription by interleukin-1 and interleukin-6. Proc. Natl. Acad. Sci. USA, 2005; 102: 1906-1910
30. Lipiński P., Starzyński R.R.: Regulacja ogólnoustrojowej homeosta-zy żelaza przez hepcydynę. Postępy Hig. Med. Dos̈w., 2004; 58: 65-73
31. Lymboussaki A., Pignatti E., Montosi G., Garuti C., Haile D.J., Pie-trangelo A.: The role of the iron responsive element in the control of ferroportin1/IREG1/MTP1 gene expression. J. Hepatol., 2003; 39: 710-715
32. Macdougall I.C., Malyszko J., Hider R.C., Bansal S.S.: Current status of the measurement of blood hepcidin levels in chronic kidney disease. Clin. J. Am. Soc. Nephrol., 2010; 5: 1681-1689
33. Malyszko J.: Hepcidin assays: Ironing out some details. Clin. J. Am. Soc. Nephrol., 2009; 4: 1015-1016
34. Nemeth E., Ganz T.: The role of hepcidin in iron metabolism. Acta Haematol., 2009; 122: 78-86
35. Nemeth E., Preza G.C., Jung C.L., Kaplan J., Waring A.J., Ganz T.: The N-terminus of hepcidin is essential for its interaction with ferroportin: Structure-function study. Blood, 2006; 107: 328-333
36. Nemeth E., Tuttle M.S., Powelson J., Vaughn M.B., Donovan A., Ward D.M., Ganz T., Kaplan J.: Hepcidin regulates cellular iron efflux by bin-ding to ferroportin and inducing its internalization. Science, 2004; 306: 2090-2093
37. Nemeth E., Valore E.V., Territo M., Schiller G., Lichtenstein A., Ganz T.: Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood, 2003; 101: 2461-2463
38. Nicolas G., Bennoun M., Devaux I., Beaumont C., Grandchamp B., Kahn A., Vaulont S.: Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc. Natl. Acad. Sci. USA, 2001; 98: 8780-8785
39. Nicolas G., Bennoun M., Porteu A., Mativet S., Beaumont C., Grand-champ B., Sirito M., Sawadogo M., Kahn A., Vaulont S.: Severe iron defi-ciency anemia in transgenic mice expressing liver hepcidin. Proc. Natl. Acad. Sci. USA, 2002; 99: 4596-4601
40. Niederkofler V., Salie R., Arber S.: Hemojuvelin is essential for die-tary iron sensing, and its mutation leads to severe iron overload. J. Clin. Invest., 2005; 115: 2180-2186
41. Oustamanolakis P., Koutroubakis I.E., Kouroumalis E.A.: Diagnosing anemia in inflammatory bowel disease: Beyond the established markers. J. Crohns Colitis, 2011; 5: 381-391
42. Oustamanolakis P., Koutroubakis I.E., Messaritakis I., Malliaraki N., Sfiridaki A., Kouroumalis E.A.: Serum hepcidin and prohepcidin concentrations in inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol., 2011; 23: 262-268
43. Park C.H., Valore E.V., Waring A.J., Ganz T.: Hepcidin, a urinary an-timicrobial peptide synthesized in the liver. J. Biol. Chem., 2001; 276: 7806-7810
44. Peslova G., Petrak J., Kuzelova K., Hrdy I., Halada P., Kuchel P.W., Soe-Lin S., Ponka P., Sutak R., Becker E., Huang M.L., Rahmanto Y.S., Richardson D.R., Vyoral D.: Hepcidin, the hormone of iron meta-bolism, is bound specifically to α-2-macroglobulin in blood. Blood, 2009; 113: 6225-6236
45. Peyssonnaux C., Zinkernagel A.S., Schuepbach R.A., Rankin E., Vau-lont S., Haase V.H., Nizet V., Johnson R.S.: Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs). J. Clin. Invest., 2007; 117: 1926-1932
46. Pigeon C., Ilyin G., Courselaud B., Leroyer P., Turlin B., Brissot P., Loréal O.: A new mouse liver-specific gene, encoding a protein homolo-gous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J. Biol. Chem., 2001; 276: 7811-7819
47. Pytrus T., Flis A., Iwańczak F., Iwańczak B.: Częstos̈ć występowania niedokrwistos̈ci u dzieci z nowo rozpoznana choroba Les̈niowskiego-Crohna. Pol. Merkur. Lekarski, 2013; 34: 263-268
48. Radwan P., Radwan-Kwiatek K., Skrzydlo-Radomańska B., Rydzew-ska G.: Niedokrwistos̈ć w nieswoistych zapaleniach jelit - etiopatoge-neza, rozpoznawanie i leczenie. Przegl. Gastroenterol., 2010; 5: 315-320
49. Reinisch W., Staun M., Bhandari S., Munoz M.: State of the iron: How to diagnose and efficiently treat iron deficiency anemia in inflammatory bowel disease. J. Crohns Colitis, 2013; 7: 429-440
50. Rivera S., Nemeth E., Gabayan V., Lopez M.A., Farshidi D., Ganz T.: Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs. Blood, 2005; 106: 2196-2199
51. Sasu B.J., Cooke K.S., Arvedson T.L., Plewa C., Ellison A.R., Sheng J., Winters A., Juan T., Li H., Begley C.G., Molineux G.: Antihepcidin antibo-dy treatment modulates iron metabolism and its effective in a mouse model of inflammation-induced anemia. Blood, 2010; 115: 3616-3624
52. Silvestri L., Pagani A., Camaschella C.: Furin-mediated release of soluble hemojuvelin: A new link between hypoxia and iron homeosta-sis. Blood, 2008; 111: 924-931
53. Sokolowska E., Klimek J.: Hepcydyna - hormon uczestniczacy w re-gulacji metabolizmu żelaza w organizmie. Postępy Biol. Kom., 2007; 34: 15-30
54. Tanno T., Bhanu N.V., Oneal P.A., Goh S.H., Staker P., Lee Y.T., Mo-roney J.W., Reed C.H., Luban N.L., Wang R.H., Eling T.E., Childs R., Ganz T., Leitman S.F., Fucharoen S., Miller J.L.: High levels of GDF15 in tha-lassemia suppress expression of the iron regulatory protein hepcidin. Nat. Med., 2007; 13: 1096-1101
55. Tanno T., Porayette P., Sripichai O., Noh S.J., Byrnes C., Bhupatiraju A., Lee Y.T., Goodnough J.B., Harandi O., Ganz T., Paulson R.F., Miller J.L.: Identification of TWSG1 as a second novel erythroid regulator of hep-cidin expression in murine and human cells. Blood, 2009; 114: 181-186
56. Van Assche G., Dignass A., Bokemeyer B., Danese S., Gionchetti P., Moser G., Beaugerie L., Gomollón F., Häuser W., Herrlinger K., Olden-burg B., Panes J., Portela F., Rogler G., Stein J. i wsp.: Second European evidence-based consensus on the diagnosis and management of ulce-rative colitis Part 3: Special situations. J. Crohns Colitis, 2013; 7: 1-33
57. Wang L., Trebicka E., Fu Y., Ellenbogen S., Hong C.C., Babitt J.L., Lin H.Y., Cherayil B.J.: The bone morphogenetic protein-hepcidin axis as a therapeutic target in inflammatory bowel disease. Inflamm. Bowel Dis., 2012; 18: 112-119
58. Wang R.H., Li C., Xu X., Zheng Y., Xiao C., Zerfas P., Cooperman S., Eckhaus M., Rouault T., Mishra L., Deng C.X.: A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metab., 2005; 2: 399-409
59. Zarychanski R., Houston D.S.: Anemia of chronic disease: A harmful disorder or an adaptive, beneficial response? CMAJ, 2008; 179: 333-337
60. Zhang D.L., Hughes R.M., Ollivierre-Wilson H., Ghosh M.C., Rouault T.A.: A ferroportin transcript that lacks an iron-responsive element enables duodenal and erythroid precursor cells to evade translational repression. Cell Metab., 2009; 9: 461-473